NPY, neuropeptide Y, 4852

N. diseases: 381; N. variants: 12
Disease: Absence Seizures ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4316903
Disease: Absence Seizures
Absence Seizures 		0.310 Biomarker phenotype BEFREE This study investigated whether NPY gene delivery to the thalamus or somatosensory cortex, using recombinant adeno-associated viral vector (rAAV), could produce sustained seizure suppression in the GAERS model of GGE with absence seizures. 29414380 2018
CUI: C4316903
Disease: Absence Seizures
Absence Seizures 		0.310 Biomarker phenotype CTD_human Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. 18005069 2007
CUI: C4316903
Disease: Absence Seizures
Absence Seizures 		0.310 Therapeutic phenotype CTD_human Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. 18005069 2007
CUI: C4316903
Disease: Absence Seizures
Absence Seizures 		0.310 Therapeutic phenotype CTD_human Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil. 16194568 2005
CUI: C4316903
Disease: Absence Seizures
Absence Seizures 		0.310 Biomarker phenotype CTD_human Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil. 16194568 2005
CUI: C4316903
Disease: Absence Seizures
Absence Seizures 		0.310 Therapeutic phenotype CTD_human Seizure susceptibility of neuropeptide-Y null mutant mice in amygdala kindling and chemical-induced seizure models. 15451008 2004
CUI: C4316903
Disease: Absence Seizures
Absence Seizures 		0.310 Biomarker phenotype CTD_human Seizure susceptibility of neuropeptide-Y null mutant mice in amygdala kindling and chemical-induced seizure models. 15451008 2004